Strenzik subcutaneous injection 18mg/0.45mL, containing Asfotase alpha (genetically recombined), is manufactured by Alexion Pharma. This injectable drug, with YJ code 3959418A2028 and standard 18mg x 0.45mL x 1 bottle bottle, is an enzyme replacement therapy for perinatal/infantile- and juvenile-onset hypophosphatasia (HPP).
Strenzik subcutaneous injection 18mg/0.45mL
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →